For women’ contains the strains Lactobacillus rhamnosus GR-1® and Lactobacillus reuteri RC-14® and is one of the most researched supplements in the whole OptiBac Probiotics range. This live cultures product has over 30 years of scientific evidence, with 26 published clinical trials, involving over 2,500 women. OptiBac Probiotics ‘For women’ has been used in clinical trials in women with thrush, cystitis and Bacterial Vaginosis (BV) and is thought to support health in those with these concerns. Healthcare professionals can read about the clinical trials on this page, or for more general information, you may wish to read the FAQ, Which probiotics are best for women?

Clinical research on 'For women' in those with thrush

In one trial, participants with thrush took a single antifungal capsule with either For women (2 capsules daily) or placebo for 4 weeks. At follow-up those who had been taking ‘For women’ had significantly fewer symptoms and yeast cell counts than the placebo group.

Clinical research on 'For women' in those with cystitis

In one trial, 252 women who suffered with recurring UTIs took ‘For women’ or antibiotics (trimethoprim-sulfamethoxazole) for one year. After 12 months the number of UTIs had more than halved in both groups, with ‘For women’ being almost as effective as antibiotics. (An impressive result for a natural remedy). Furthermore, after 1 month in the antibiotic group, 90% antibiotic resistance had been developed to the prescribed medication. This of course was not an issue in the probiotic group, where antibiotic resistance (likely from previous medication) was shown to decrease.

Clinical research on 'For women' in those with Bacterial Vaginosis (BV)

In one trial, 125 women with BV took antibiotics for 1 week, alongside For women (2 caps daily) or placebo during this week, as well as for 3 weeks afterwards. BV cleared up in just 40% of those who took antibiotics alone, whereas BV was resolved in 88% of those who took ‘For women’ with the antibiotics. OptiBac Probiotics ‘For women’ doubled the efficacy of the treatment.

Clinical research showing survival of 'For women' strains

The following trials demonstrate that both strains in ‘For women’ have been found in vaginal swabs after oral administration.

'For women' in clinical trials for regulating the immune system

'For women' in clinical trials for immunity and other health conditions